FDA Inspection 1236122 — K2M, Inc.
The FDA completed an inspection of K2M, Inc. on March 21, 2024 in Leesburg, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Leesburg, VA (United States)